Skip to main
ESTA

ESTA Stock Forecast & Price Target

ESTA Analyst Ratings

Based on 7 analyst ratings
Buy
Strong Buy 43%
Buy 43%
Hold 14%
Sell 0%
Strong Sell 0%

Bulls say

Establishment Labs Holdings Inc. has demonstrated a significant improvement in its financial performance, with an EBITDA margin that increased 1,960 basis points year-over-year and a gross margin of 70.1%, surpassing consensus expectations. The company's strategic launch of the Motiva implants has revitalized the breast aesthetics market, contributing to approximately 15% year-over-year growth in procedure volumes among practices offering these products. Additionally, the positive outlook is further supported by projected cash reserves of $75.5 million by the end of 2026, up from $71 million in the third quarter of 2025, indicating robust financial health and growth potential.

Bears say

Establishment Labs Holdings Inc. faces significant challenges, as revenue growth is projected to decrease to below 20% due to weaker-than-expected sales in the U.S. market, compounded by slow progress towards profitability. Additionally, international growth has markedly slowed, with estimates suggesting approximately 2% growth in 2023, a 2% decline in 2024, and a return to 2% growth in 2025. The company also confronts multiple risks, including disappointing sales performance, potential economic downturns affecting international sales, and concerns regarding real-world complication rates, which could further impact its financial stability.

ESTA has been analyzed by 7 analysts, with a consensus rating of Buy. 43% of analysts recommend a Strong Buy, 43% recommend Buy, 14% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Establishment Labs Holdings Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Establishment Labs Holdings Inc (ESTA) Forecast

Analysts have given ESTA a Buy based on their latest research and market trends.

According to 7 analysts, ESTA has a Buy consensus rating as of Jan 19, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $78.86, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $78.86, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Establishment Labs Holdings Inc (ESTA)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.